The role of the endocannabinoid system in pain - PubMed (original) (raw)
Review
The role of the endocannabinoid system in pain
Stephen G Woodhams et al. Handb Exp Pharmacol. 2015.
Abstract
Preparations of the Cannabis sativa plant have been used to analgesic effect for millenia, but only in recent decades has the endogenous system responsible for these effects been described. The endocannabinoid (EC) system is now known to be one of the key endogenous systems regulating pain sensation, with modulatory actions at all stages of pain processing pathways. The EC system is composed of two main cannabinoid receptors (CB1 and CB2) and two main classes of endogenous ligands or endocannabinoids (ECs). The receptors have distinct expression profiles, with CB1 receptors found at presynaptic sites throughout the peripheral and central nervous systems (PNS and CNS, respectively), whilst CB2 receptor is found principally (but not exclusively) on immune cells. The endocannabinoid ligands are lipid neurotransmitters belonging to either the N-acyl ethanolamine (NAEs) class, e.g. anandamide (AEA), or the monoacylglycerol class, e.g. 2-arachidonoyl glycerol (2-AG). Both classes are short-acting transmitter substances, being synthesised on demand and with signalling rapidly terminated by specific enzymes. ECs acting at CB1 negatively regulate neurotransmission throughout the nervous system, whilst those acting at CB2 regulate the activity of CNS immune cells. Signalling through both of these receptor subtypes has a role in normal nociceptive processing and also in the development resolution of acute pain states. In this chapter, we describe the general features of the EC system as related to pain and nociception and discuss the wealth of preclinical and clinical data involving targeting the EC system with focus on two areas of particular promise: modulation of 2-AG signalling via specific enzyme inhibitors and the role of spinal CB2 in chronic pain states.
Similar articles
- Endocannabinoid system and pain: an introduction.
Burston JJ, Woodhams SG. Burston JJ, et al. Proc Nutr Soc. 2014 Feb;73(1):106-17. doi: 10.1017/S0029665113003650. Epub 2013 Oct 22. Proc Nutr Soc. 2014. PMID: 24148358 Review. - The neurobiology and evolution of cannabinoid signalling.
Elphick MR, Egertová M. Elphick MR, et al. Philos Trans R Soc Lond B Biol Sci. 2001 Mar 29;356(1407):381-408. doi: 10.1098/rstb.2000.0787. Philos Trans R Soc Lond B Biol Sci. 2001. PMID: 11316486 Free PMC article. Review. - The endogenous cannabinoid system and its role in nociceptive behavior.
Cravatt BF, Lichtman AH. Cravatt BF, et al. J Neurobiol. 2004 Oct;61(1):149-60. doi: 10.1002/neu.20080. J Neurobiol. 2004. PMID: 15362158 Review. - Endocannabinoid system: An overview of its potential in current medical practice.
Mouslech Z, Valla V. Mouslech Z, et al. Neuro Endocrinol Lett. 2009;30(2):153-79. Neuro Endocrinol Lett. 2009. PMID: 19675519 Review. - The fundamental role of the endocannabinoid system in endometrium and placenta: implications in pathophysiological aspects of uterine and pregnancy disorders.
Maia J, Fonseca BM, Teixeira N, Correia-da-Silva G. Maia J, et al. Hum Reprod Update. 2020 Jun 18;26(4):586-602. doi: 10.1093/humupd/dmaa005. Hum Reprod Update. 2020. PMID: 32347309 Free PMC article. Review.
Cited by
- Chemotherapy-Induced Peripheral Neuropathy: A Recent Update on Pathophysiology and Treatment.
Mattar M, Umutoni F, Hassan MA, Wamburu MW, Turner R, Patton JS, Chen X, Lei W. Mattar M, et al. Life (Basel). 2024 Aug 9;14(8):991. doi: 10.3390/life14080991. Life (Basel). 2024. PMID: 39202733 Free PMC article. Review. - Hypothalamic cannabinoid signaling: Consequences for eating behavior.
Lord MN, Noble EE. Lord MN, et al. Pharmacol Res Perspect. 2024 Oct;12(5):e1251. doi: 10.1002/prp2.1251. Pharmacol Res Perspect. 2024. PMID: 39155548 Free PMC article. Review. - Impact of Medical Cannabis on Recovery from Playing-Related Musculoskeletal Disorders in Musicians: An Observational Cohort Study.
Cottrell K, Chong J. Cottrell K, et al. Healthcare (Basel). 2024 Jul 4;12(13):1335. doi: 10.3390/healthcare12131335. Healthcare (Basel). 2024. PMID: 38998869 Free PMC article. - Anandamide-Mediated Modulation of Nociceptive Transmission at the Spinal Cord Level.
Spicarova D, Palecek J. Spicarova D, et al. Physiol Res. 2024 Aug 30;73(S1):S435-S448. doi: 10.33549/physiolres.935371. Epub 2024 Jul 2. Physiol Res. 2024. PMID: 38957948 Free PMC article. Review. - Structure-based identification of a G protein-biased allosteric modulator of cannabinoid receptor CB1.
Shen S, Wu C, Lin G, Yang X, Zhou Y, Zhao C, Miao Z, Tian X, Wang K, Yang Z, Liu Z, Guo N, Li Y, Xia A, Zhou P, Liu J, Yan W, Ke B, Yang S, Shao Z. Shen S, et al. Proc Natl Acad Sci U S A. 2024 Jun 11;121(24):e2321532121. doi: 10.1073/pnas.2321532121. Epub 2024 Jun 3. Proc Natl Acad Sci U S A. 2024. PMID: 38830102
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical